Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Muye Xia"'
Autor:
Han Zhao, Shaohang Cai, Yanhua Xiao, Muye Xia, Hongjie Chen, Zhiman Xie, Xiaoping Tang, Haolan He, Jie Peng, Juanjuan Chen
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Objective Immune tolerance and evasion play a critical role in virus‐driven malignancies. However, the phenotype and clinical significance of programmed cell death 1 (PD‐1) and its ligands, PD‐L1 and PD‐L2, in aggressive acquired imm
Externí odkaz:
https://doaj.org/article/a3a2741e83ed4fa0826130a4710ec85a
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
IntroductionThere are limited data on the efficacy of baloxavir marboxil (baloxavir) versus oseltamivir in Chinese patients with influenza A.MethodsThis study is an observational real-world investigation encompassing 246 patients (baloxavir, n = 147;
Externí odkaz:
https://doaj.org/article/8505c8575c714515891e4cc93dcf3935
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 2, Pp 637-647 (2023)
Abstract Introduction Although the indications for antiviral therapy for patients with chronic hepatitis B have been gradually expanded in different guidelines, antiviral treatment efficacy remains unclear among HBeAg-seropositive patients with alani
Externí odkaz:
https://doaj.org/article/b460c26228274e1ea42bc63ce6fae43b
Autor:
Linqing Xie, Guichan Liao, Hongjie Chen, Muye Xia, Xuan Huang, Rong Fan, Jie Peng, Xiaoyong Zhang, Hongyan Liu
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background The virological or clinical relapse is common in chronic hepatitis B (CHB) patients after stopping long-term nucleos(t)ide analogue (NA) therapy. Soluble growth stimulation expressed gene 2 (sST2), one of the Toll-like/interleukin
Externí odkaz:
https://doaj.org/article/3b78b3e13bbe4ecfafedd6c859869cb0
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Chronic hepatitis B (CHB) infection remains worldwide health problem. Antiviral treatment options for CHB patients include nucleos(t)ide analogs (NAs) and interferon. Most of the current biomarkers for predicting treatment response are virus-dependen
Externí odkaz:
https://doaj.org/article/2d85234fa9ad40dcbe87537bb3b57f96
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 10 (2017)
Objective: The objective of this study was to develop a noninvasive diagnostic test for nonalcoholic hepatic steatosis in patients with chronic hepatitis B (CHB) by using routinely available clinical markers. Methods: A retrospective study of patient
Externí odkaz:
https://doaj.org/article/947cad0b832d41d58f78f97fdd30c03d
Publikováno v:
International Journal of General Medicine
Yunqing Sun,* Zhuohong Li,* Guichan Liao, Muye Xia, Xuwen Xu, Shaohang Cai, Jie Peng Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, Peopleâs Republic of China*These au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd2138eb77d7562b6c7fd0184c530f7
https://doi.org/10.2147/ijgm.s343457
https://doi.org/10.2147/ijgm.s343457
Autor:
Xiaoyong Zhang, Heng Chi, Jinlin Hou, Bettina E. Hansen, Yaobo Wu, Zhandong Li, Harry L.A. Janssen, Guichan Liao, Muye Xia, Shi Liu, Jian Sun, Jie Peng, Bin Zhou
Publikováno v:
Alimentary Pharmacology and Therapeutics, 54(5), 709-714. Wiley-Blackwell Publishing Ltd
Background: Nucleos(t)ide analogue (NA) discontinuation may be attempted in carefully selected patients with chronic hepatitis B (CHB) infection. Aim: To investigate whether a novel serum marker of quantitative hepatitis B virus (HBV) RNA levels coul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eec591f5b836f38c6ea2520ea5dc392
https://doi.org/10.1111/apt.16538
https://doi.org/10.1111/apt.16538
Autor:
Guichan Liao, Ziying Liu, Muye Xia, Hongjie Chen, Houji Wu, Bing Li, Tao Yu, Shaohang Cai, Xiaoyong Zhang, Jie Peng
Publikováno v:
Infection and Drug Resistance.
Guichan Liao, Ziying Liu, Muye Xia, Hongjie Chen, Houji Wu, Bing Li, Tao Yu, Shaohang Cai, Xiaoyong Zhang, Jie Peng State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f73bbc77748c00481e2fbb23db2aa1
https://www.dovepress.com/soluble-programmed-cell-death-1-is-a-novel-predictor-of-hbsag-loss-in--peer-reviewed-fulltext-article-IDR
https://www.dovepress.com/soluble-programmed-cell-death-1-is-a-novel-predictor-of-hbsag-loss-in--peer-reviewed-fulltext-article-IDR
Publikováno v:
Infection and Drug Resistance
Xin Ji,* Muye Xia,* Bin Zhou, Shi Liu, GuiChan Liao, Shaohang Cai, Xiaoyong Zhang, Jie Peng State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4d2bca04fbbbe59c6eefb428cd199a2
https://doi.org/10.2147/idr.s252994
https://doi.org/10.2147/idr.s252994